Clinical trial
A Rheumatoid Arthritis (RA) Study Treating Signs and Symptoms of RA in People…
NCT00038298 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00038298 |
|---|---|
| Title | A Rheumatoid Arthritis (RA) Study Treating Signs and Symptoms of RA in People With RA & Receiving Methotrexate |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study to Assess the Efficacy, Safety and Tolerability of AMG 719 in Subjects With Rheumatoid Arthritis Receiving Methothrexate |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | Placebo, AMG 719, AGM 719, placebo to AMG 719 |
| Enrollment | 53 |
| Start date | Apr 1, 2002 |
| Primary completion | May 1, 2004 |
| Completion | May 1, 2004 |
| First posted | May 31, 2002 |
| Last update posted | Jan 21, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: